Data / Form D filings / InSitu Biologics, Inc.
InSitu Biologics, Inc.: Form D filing
InSitu Biologics, Inc., a biotechnology company in Oakdale, MN, filed a Form D with the SEC in 2026. The latest, on October 14, 2026, reports $1.3 million sold of a $3.4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3510 HOPKINS PLACE N. BUILDING 4, Oakdale, MN, 55128
- Phone
- (651) 337-4799
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1723443
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 14 | Amendment | $3,375,000 | $1,250,000 | $2,125,000 | 1 | Aug 4 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Halpern | Executive Officer, Director | |
| Bill Taylor | Executive Officer | |
| Sandi Klemann | Executive Officer | |
| Robert Wilson | Director | |
| Greg Van Guilder | Director | |
| Ivan Shaw | Director |
Every Form D from the week of Oct 12 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what InSitu Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.